linkedin post 2020-03-03 04:17:33

KEY STEP. “Last year, bioengineer Daniel Anderson of the Massachusetts Institute of Technology in Cambridge and his colleagues used CRISPR in mice to correct a mutation associated with a human metabolic disease called tyrosinaemia. It was the first use of CRISPR to fix a disease-causing mutation in an adult animal — and an important step towards using the technology for gene therapy in humans.”

http://www.nature.com/news/crispr-the-disruptor-1.17673

View in LinkedIn

Share the knowledge
Share the knowledge

SEARCH:

Search

CATEGORIES:

IT MIGHT BE OF YOUR INTEREST: